









Mercado
/
Acciones
/
nasdaq-holx
/

Hologic Inc

HOLX

73.910USD

-0.020-0.03%

Cierre 10/31, 16:00（ET）Cotizaciones retrasadas 15 min

16.42BCap. mercado

29.48P/E TTM



Hologic Inc

73.910

-0.020-0.03%

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Hologic Inc Compañía

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Información de Hologic Inc



Símbolo de cotizaciónHOLX

Nombre de la empresaHologic Inc

Fecha de salida a bolsaMar 01, 1990

Director ejecutivoMr. Stephen P. (Steve) Macmillan

Número de empleados7063

Tipo de seguridadOrdinary Share

Fin del año fiscalMar 01

Dirección250 Campus Drive

CiudadMARLBOROUGH

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal01752

Teléfono15082632900

Sitio Webhttps://www.hologic.com/

Símbolo de cotizaciónHOLX

Fecha de salida a bolsaMar 01, 1990

Director ejecutivoMr. Stephen P. (Steve) Macmillan

Ejecutivos de Hologic Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

Ms. Christiana Stamoulis

Independent Director

47.34K

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Mr. Mark Horvath

Division President, Breast and Skeletal Health Solutions

7.06K

+15.71%

Mr. Brandon Schnittker

Division President, GYN Surgical Solutions

6.09K

-1.12%

Ms. Nanaz Mohtashami

Independent Director

4.18K

+80.45%

Ms. Stacey D. Stewart

Independent Director

3.60K

+107.62%

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Stephen P. (Steve) Macmillan

Chairman of the Board, President, Chief Executive Officer

1.22M

Ms. Christiana Stamoulis

Independent Director

47.34K

Mr. Charles J. Dockendorff, CPA

Independent Director

18.81K

+11.00%

Ms. Diana De Walt

Senior Vice President - Human Resources

12.02K

Mr. Essex D. Mitchell

Chief Operating Officer

9.93K

-34.65%

Dr. Ludwig N. Hantson, Ph.D.

Independent Director

9.26K

+25.20%

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Disposables

658.40M

64.31%

Service

208.80M

20.39%

Capital equipment, components and software

152.00M

14.85%

Other

4.60M

0.45%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

760.70M

74.30%

Europe

148.10M

14.47%

Asia

60.30M

5.89%

Rest of World

54.70M

5.34%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Disposables

658.40M

64.31%

Service

208.80M

20.39%

Capital equipment, components and software

152.00M

14.85%

Other

4.60M

0.45%

Estadísticas de accionistas

Actualizado: mié., 22 de oct

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

12.00%

T. Rowe Price Investment Management, Inc.

10.82%

BlackRock Institutional Trust Company, N.A.

5.82%

Manulife Investment Management (North America) Limited

4.95%

State Street Investment Management (US)

4.54%

Otro

61.87%

Accionistas

Proporción

The Vanguard Group, Inc.

12.00%

T. Rowe Price Investment Management, Inc.

10.82%

BlackRock Institutional Trust Company, N.A.

5.82%

Manulife Investment Management (North America) Limited

4.95%

State Street Investment Management (US)

4.54%

Otro

61.87%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

59.24%

Investment Advisor/Hedge Fund

28.04%

Hedge Fund

5.44%

Research Firm

2.46%

Pension Fund

2.45%

Bank and Trust

1.48%

Sovereign Wealth Fund

1.28%

Individual Investor

0.85%

Family Office

0.05%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

1586

223.54M

100.44%

-14.31M

2025Q2

1594

230.47M

103.62%

-13.07M

2025Q1

1635

231.71M

103.94%

-14.47M

2024Q4

1617

238.36M

106.18%

-10.05M

2024Q3

1583

240.17M

103.42%

-3.00M

2024Q2

1580

234.77M

100.61%

-6.88M

2024Q1

1595

233.34M

99.37%

-7.61M

2023Q4

1584

235.52M

98.14%

-14.13M

2023Q3

1574

242.15M

98.88%

-13.93M

2023Q2

1583

245.52M

99.77%

-12.39M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

26.70M

12%

-16.89K

-0.06%

Jun 30, 2025

T. Rowe Price Investment Management, Inc.

24.08M

10.83%

+6.39M

+36.15%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

12.95M

5.82%

-509.21K

-3.78%

Jun 30, 2025

Manulife Investment Management (North America) Limited

11.02M

4.96%

+8.23M

+294.34%

Jun 30, 2025

State Street Investment Management (US)

10.10M

4.54%

-14.24K

-0.14%

Jun 30, 2025

Geode Capital Management, L.L.C.

5.83M

2.62%

+97.14K

+1.69%

Jun 30, 2025

Victory Capital Management Inc.

5.50M

2.47%

-1.11M

-16.81%

Jun 30, 2025

Invesco Advisers, Inc.

4.33M

1.95%

+3.88M

+868.40%

Jun 30, 2025

Black Creek Investment Management, Inc.

4.03M

1.81%

+832.44K

+26.05%

Jun 30, 2025

Invesco Capital Management LLC

4.01M

1.8%

-361.78K

-8.28%

Jun 30, 2025

ETFs relacionados



Actualizado: lun., 6 de oct

Nombre

Proporción

First Trust Nasdaq Lux Digi Health Solutions ETF

4.21%

Otter Creek Focus Strategy ETF

4.02%

John Hancock Fundamental All Cap Core ETF

3.4%

LeaderShares AlphaFactor Tactical Focused ETF

3.23%

First Trust Indxx Medical Devices ETF

2.14%

Formidable ETF

SPDR S&P Health Care Equipment ETF

1.88%

Strategas Global Policy Opportunities ETF

1.8%

Brandes US Small-Mid Cap Value ETF

1.75%

iShares U.S. Medical Devices ETF

1.71%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción4.21%

Otter Creek Focus Strategy ETF

Proporción4.02%

John Hancock Fundamental All Cap Core ETF

Proporción3.4%

LeaderShares AlphaFactor Tactical Focused ETF

Proporción3.23%

First Trust Indxx Medical Devices ETF

Proporción2.14%

Formidable ETF

Proporción2%

SPDR S&P Health Care Equipment ETF

Proporción1.88%

Strategas Global Policy Opportunities ETF

Proporción1.8%

Brandes US Small-Mid Cap Value ETF

Proporción1.75%

iShares U.S. Medical Devices ETF

Proporción1.71%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

